DNA Damage Response Inhibitors Enhance Tumour Treating Fields (TTFields) Potency in Glioma Stem-Like Cells

The authors used patient-derived, typically resistant, glioma stem-like cells in combination with the previously validated preclinical Inovitro™ TTFields system together with a number of therapeutic DNA damage response inhibitors.